Merck ROE 2010-2024 | MKKGY
Current and historical return on equity (ROE) values for Merck (MKKGY) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| Merck ROE - Return on Equity Historical Data |
| Date |
TTM Net Income |
Shareholder's Equity |
Return on Equity |
| 2024-06-30 |
$2.84B |
$30.82B |
9.39% |
| 2024-03-31 |
$2.96B |
$30.48B |
9.90% |
| 2023-12-31 |
$3.06B |
$28.96B |
10.44% |
| 2023-09-30 |
$3.09B |
$30.80B |
10.70% |
| 2023-06-30 |
$3.22B |
$29.19B |
11.36% |
| 2023-03-31 |
$3.37B |
$28.16B |
12.06% |
| 2022-12-31 |
$3.51B |
$27.40B |
12.81% |
| 2022-09-30 |
$3.76B |
$28.54B |
14.01% |
| 2022-06-30 |
$3.73B |
$27.70B |
14.44% |
| 2022-03-31 |
$3.70B |
$25.80B |
14.98% |
| 2021-12-31 |
$3.62B |
$25.34B |
15.07% |
| 2021-09-30 |
$3.20B |
$24.39B |
14.23% |
| 2021-06-30 |
$3.25B |
$23.33B |
14.98% |
| 2021-03-31 |
$2.67B |
$22.89B |
12.82% |
| 2020-12-31 |
$2.27B |
$19.44B |
11.23% |
| 2020-09-30 |
$2.12B |
$21.04B |
10.39% |
| 2020-06-30 |
$1.56B |
$19.85B |
7.72% |
| 2020-03-31 |
$1.77B |
$20.52B |
8.77% |
| 2019-12-31 |
$1.48B |
$20.06B |
7.38% |
| 2019-09-30 |
$4.00B |
$20.22B |
19.91% |
| 2019-06-30 |
$4.02B |
$19.75B |
20.58% |
| 2019-03-31 |
$3.78B |
$20.08B |
19.89% |
| 2018-12-31 |
$3.99B |
$20.35B |
21.75% |
| 2018-09-30 |
$2.27B |
$17.84B |
13.20% |
| 2018-06-30 |
$2.63B |
$17.76B |
15.68% |
| 2018-03-31 |
$2.80B |
$17.34B |
17.35% |
| 2017-12-31 |
$2.94B |
$15.90B |
18.75% |
| 2017-09-30 |
$2.06B |
$16.21B |
13.25% |
| 2017-06-30 |
$1.82B |
$15.14B |
11.98% |
| 2017-03-31 |
$1.71B |
$15.43B |
11.37% |
| 2016-12-31 |
$1.80B |
$15.55B |
12.34% |
| 2016-09-30 |
$1.65B |
$14.50B |
11.56% |
| 2016-06-30 |
$1.55B |
$14.52B |
10.64% |
| 2016-03-31 |
$1.58B |
$13.86B |
10.67% |
| 2015-12-31 |
$1.25B |
$14.27B |
8.19% |
| 2015-09-30 |
$1.42B |
$15.60B |
9.13% |
| 2015-06-30 |
$1.35B |
$15.38B |
8.63% |
| 2015-03-31 |
$1.37B |
$15.60B |
8.79% |
| 2014-12-31 |
$1.50B |
$15.69B |
9.63% |
| 2014-09-30 |
$1.56B |
$15.64B |
10.23% |
| 2014-06-30 |
$1.68B |
$15.39B |
11.26% |
| 2014-03-31 |
$1.70B |
$15.41B |
11.67% |
| 2013-12-31 |
$1.60B |
$14.70B |
11.27% |
| 2013-09-30 |
$1.56B |
$14.28B |
11.31% |
| 2013-06-30 |
$1.35B |
$13.76B |
9.92% |
| 2013-03-31 |
$0.85B |
$13.89B |
6.28% |
| 2012-12-31 |
$0.73B |
$13.39B |
7.23% |
| 2012-09-30 |
$0.55B |
$13.22B |
5.36% |
| 2012-06-30 |
$0.64B |
$13.54B |
9.14% |
| 2012-03-31 |
$0.60B |
|
8.09% |
| 2011-12-31 |
$0.84B |
$14.62B |
11.40% |
| 2011-09-30 |
$0.75B |
|
20.19% |
| 2011-06-30 |
$0.70B |
$14.90B |
9.87% |
| 2011-03-31 |
$1.05B |
|
30.94% |
| 2010-12-31 |
$0.84B |
|
24.73% |
| 2010-09-30 |
$0.83B |
$13.59B |
24.53% |
| 2010-06-30 |
$0.77B |
|
inf% |
| 2010-03-31 |
$0.69B |
|
inf% |
| 2009-12-31 |
$0.51B |
|
inf% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-DRUGS |
$21.306B |
$22.719B |
|
Merck is a global pharmaceutical and chemical company. Its success is characterized by innovations from entrepreneurial employees. Merck's operating activities come under the umbrella of Merck KGaA, in which the Merck family holds an approximately 70% interest and free shareholders own the remaining approximately 30%. In 1917 the U.S. subsidiary Merck & Co. was expropriated and has been an independent company ever since.
|
